## A Systematic Review and Network Meta-analysis of First-line Immune Checkpoint Inhibitors Combination Therapies in Patients with Advanced Nonsquamous NSCLC

#### Journal: Frontiers in Immunology<br>Doi: 10.3389/fimmu.2022.948597

Taihang Shao<sup>1*</sup>, Mingye Zhao<sup>1*</sup>, Leyi Liang<sup>1</sup>, Wenxi Tang<sup>1,2#</sup>

1 Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China, 211198; <br>
2 Department of Public Affairs Management, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China, 211198

*These authors contributed equally to this work; <br>
#Corresponding authors

*Codes in this repository are used to reproduce this analysis.*<br>
*Original data and colour figures are also provided in this repository.*<br>
*Working directory of some code files should be changed as your own.*<br>
*Software needed:R, WinBUGs and Stata.*

### Any questions or technical consulting:
Email: cpu_sth@stu.cpu.edu.cn

### Edit History
Time: 2022/09/09<br>
#Added the codes to plot the network plot<br>
Time: 2022/09/12<br>
#Added the codes to plot the funnel plot<br>
Time: 2023/4/21<br>
#Added the codes for RP NMA models with 1 knot and 3 knots. RP NMA model with 4 knots was not included since there was evidence of overfit. Original data and codes were provided.(Data of melanoma network please refer to Suzanne C Freeman et.al. 2022, DOI: 10.1177/09622802211070253)<br>
